Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany
Wahler, S, Müller, A, Koll, C, Seyed-Abbaszadeh, P, Von Der Schulenburg, JM
Published in Journal of market access & health policy (2021)
Published in Journal of market access & health policy (2021)
Get full text
Journal Article
EPH260 Rare Diseases and Kidney Stones: Are Stones in Amino Acid Transport Disorders Special?
Wahler, S., Koll, C., Müller, A., Seyed-Abbaszadeh, P., Oh, J.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article